<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02896387</url>
  </required_header>
  <id_info>
    <org_study_id>EGN_2016_14</org_study_id>
    <nct_id>NCT02896387</nct_id>
  </id_info>
  <brief_title>Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63</brief_title>
  <acronym>PRIMAculture</acronym>
  <official_title>Ex Vivo and in Vitro Assessment of the Pharmacological Properties of Molecule Prima in the Restoration of Physiological Differentiation of Gene p63 Dependant Epithelium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ectodermal dysplasia associated with p63 is a rare disease which, in addition to limbic
      abnormalities, primarily affects the skin and cornea. The most common forms are called
      Ectrodactyly, Ectodermal dysplasia, palate Key for cleft lip and palate (EEC) and
      Ankyloblepharon, Ectodermal dysplasia, cleft lip and palate (AEC). Apart from symptomatic
      treatment, no cure is available. To understand the molecular defects associated with this
      disease and to identify therapeutic tools, a research team modelized the disease by
      reprograming EEC and AEC patient fibroblasts in pluripotent stem cells (iPSC), then induced
      iPSC differentiation in patients and controls epidermal (skin) and limbic (cornea) cells and
      demonstrated that the mutated cells can reproduce in vitro the abnormalities observed in
      patients.

      P63 gene belongs to the family of p53 gene. The functions of the two proteins are very
      similar. Data suggest that molecule Prima could reactivate the p63 protein mutated in
      patients and thus alleviate skin defect healing and limbic regeneration.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 3, 2017</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the differentiation of corneal epithelium by histological observation</measure>
    <time_frame>baseline</time_frame>
    <description>the differentiation of corneal epithelium by histological observation</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ectodermal Dysplasia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with genetic pathology of the ocular surface
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with genetic pathology of the ocular surface

          -  Age ≥ 7 years

        Exclusion Criteria:

          -  Agonal glaucoma

          -  low vision mostly related to retinal pathology

          -  Pregnant or breast-feeding patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric GABISON</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation ophtalmologique de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD, PhD</last_name>
    <phone>0033148036431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Opthalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric GABISON</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Smail HADJ RABIA</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2016</study_first_submitted>
  <study_first_submitted_qc>September 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2016</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ectodermal Dysplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

